ABBV logo

AbbVie (ABBV) EBITDA

Annual EBITDA

$9.14 B
-$8.04 B-46.79%

December 1, 2024

Summary

Performance

1-Year Change

-46.79%

3-Year Change

-61.82%

5-Year Change

-25.27%

15-Year Change

-11.96%

ABBV EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

98.87%
ABBV annual EBITDA is higher than 98.87% of companies in Healthcare sector

High & Low

All-time High

$24.17 B
ABBV annual EBITDA is currently -62.20% below its historical high of $24.17 billion

3-Year Low

$9.14 B
ABBV annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2024
ABBV previous annual earnings announcement was published on Dec 1, 2024

Next Annual Earnings Report Date

N/A
ABBV next annual earnings announcement has not yet been scheduled

OtherABBVprofitabilitymetrics:

Annual Revenue

$56.33 B
ABBV annual revenue is $56.33 billion

Annual Net Income

$4.28 B
ABBV annual net profit is $4.28 billion

Annual EBIT

$9.14 B
ABBV annual earnings before interest & taxes is $9.14 billion

Annual EPS

$2.39
ABBV annual earnings per share is $2.39

Quarterly EBITDA

-$1.49 B
-$6.37 B-130.51%

December 1, 2024

Summary

Performance

3-Month Change

-130.51%

1-Year Change

-130.51%

3-Year Change

-139.3%

5-Year Change

-135.97%

ABBV Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

0.08%
ABBV quarterly EBITDA is higher than 0.08% of companies in Healthcare sector

High & Low

All-time High

$7.53 B
ABBV quarterly EBITDA is currently -119.79% below its historical high of $7.53 billion

3-Year Low

-$1.49 B
ABBV quarterly EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ABBV previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
ABBV next earnings announcement is scheduled for Apr 25, 2025

OtherABBVprofitabilitymetrics:

Quarterly Revenue

$15.10 B
ABBV quarterly revenue is $15.10 billion

Quarterly Net Income

-$22.00 M
ABBV quarterly net profit is -$22.00 million

Quarterly EBIT

-$1.49 B
ABBV quarterly earnings before interest & taxes is -$1.49 billion

Quarterly EPS

-$0.02
ABBV quarterly earnings per share is -$0.02

TTM EBITDA

$12.88 B
-$5.34 B-29.31%

December 1, 2024

Summary

Performance

3-Month Change

-29.31%

1-Year Change

-29.31%

3-Year Change

-47.54%

5-Year Change

+5.38%

ABBV TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

99.24%
ABBV TTM EBITDA is higher than 99.24% of companies in Healthcare sector

High & Low

All-time High

$25.32 B
ABBV TTM EBITDA is currently -49.10% below its historical high of $25.32 billion

3-Year Low

$12.88 B
ABBV TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 1, 2024
ABBV previous earnings announcement was published on Dec 1, 2024

Next Quarterly Earnings Report Date

Apr 25, 2025
ABBV next earnings announcement is scheduled for Apr 25, 2025

OtherABBVprofitabilitymetrics:

TTM Revenue

$56.33 B
ABBV TTM revenue is $56.33 billion

TTM Net Income

$4.28 B
ABBV TTM net profit is $4.28 billion

TTM EBIT

$6.60 B
ABBV TTM earnings before interest & taxes is $6.60 billion

TTM EPS

$2.40
ABBV TTM earnings per share is $2.40

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

$9.14 B
ABBV annual EBITDA is $9.14 billion

Annual Net Income

$4.28 B
ABBV annual net profit is $4.28 billion

Annual Interest Expense

-
ABBV annual interest expense value is unknown

Annual Income Tax

-$570.00 M
ABBV annual income tax is -$570.00 million

Annual D&A

-
ABBV annual depreciation & amortization value is unknown

ABBV EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-46.8%-130.5%-29.3%
3 y3 years-61.8%-139.3%-47.5%
5 y5 years-25.3%-136.0%+5.4%

ABBV EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-62.2%at low-119.8%at low-49.1%at low
5 y5-year-62.2%at low-119.8%at low-49.1%+5.4%
alltimeall time-62.2%+154.9%-119.8%+3.9%-49.1%+940.0%

AbbVie EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
$9.14 B(-46.8%)
-$1.49 B(-130.5%)
$12.88 B(-29.3%)
Sep 2024
-
$4.88 B(-2.4%)
$18.23 B(+0.8%)
Jun 2024
-
$5.00 B(+11.5%)
$18.09 B(-2.3%)
Mar 2024
-
$4.49 B(+16.5%)
$18.51 B(+7.8%)
Dec 2023
$17.17 B(-29.0%)
$3.85 B(-18.8%)
$17.17 B(-9.7%)
Sep 2023
-
$4.74 B(-12.5%)
$19.01 B(-11.3%)
Jun 2023
-
$5.42 B(+71.9%)
$21.43 B(+8.2%)
Mar 2023
-
$3.15 B(-44.5%)
$19.80 B(-18.1%)
Dec 2022
$24.17 B(+1.0%)
$5.69 B(-20.6%)
$24.17 B(-4.5%)
Sep 2022
-
$7.17 B(+89.0%)
$25.32 B(+3.1%)
Jun 2022
-
$3.79 B(-49.7%)
$24.56 B(-0.8%)
Mar 2022
-
$7.53 B(+10.2%)
$24.75 B(+3.4%)
Dec 2021
$23.93 B(+94.2%)
$6.83 B(+6.5%)
$23.93 B(+30.9%)
Sep 2021
-
$6.41 B(+61.2%)
$18.29 B(+5.7%)
Jun 2021
-
$3.98 B(-40.8%)
$17.30 B(+16.8%)
Mar 2021
-
$6.71 B(+465.6%)
$14.82 B(+20.2%)
Dec 2020
$12.32 B(+0.8%)
$1.19 B(-78.1%)
$12.32 B(-19.3%)
Sep 2020
-
$5.42 B(+262.9%)
$15.28 B(+19.0%)
Jun 2020
-
$1.49 B(-64.6%)
$12.84 B(-1.3%)
Mar 2020
-
$4.22 B(+1.9%)
$13.01 B(+6.4%)
Dec 2019
$12.23 B(+47.1%)
$4.14 B(+38.8%)
$12.23 B(+87.1%)
Sep 2019
-
$2.98 B(+79.0%)
$6.53 B(-7.8%)
Jun 2019
-
$1.67 B(-51.5%)
$7.08 B(-13.5%)
Mar 2019
-
$3.43 B(-321.4%)
$8.19 B(-1.4%)
Dec 2018
$8.31 B(-19.9%)
-$1.55 B(-143.9%)
$8.31 B(-29.1%)
Sep 2018
-
$3.54 B(+27.4%)
$11.72 B(+7.0%)
Jun 2018
-
$2.77 B(-21.9%)
$10.95 B(-2.2%)
Mar 2018
-
$3.55 B(+90.8%)
$11.20 B(+7.9%)
Dec 2017
$10.38 B
$1.86 B(-32.7%)
$10.38 B(-7.0%)
DateAnnualQuarterlyTTM
Sep 2017
-
$2.77 B(-8.3%)
$11.16 B(+1.6%)
Jun 2017
-
$3.02 B(+10.4%)
$10.98 B(+3.6%)
Mar 2017
-
$2.73 B(+3.4%)
$10.59 B(+4.7%)
Dec 2016
$10.12 B(+23.4%)
$2.64 B(+2.0%)
$10.12 B(+2.5%)
Sep 2016
-
$2.59 B(-1.6%)
$9.87 B(+5.4%)
Jun 2016
-
$2.63 B(+16.4%)
$9.36 B(+6.7%)
Mar 2016
-
$2.26 B(-5.6%)
$8.77 B(+7.0%)
Dec 2015
$8.20 B(+128.8%)
$2.39 B(+15.0%)
$8.20 B(+60.7%)
Sep 2015
-
$2.08 B(+2.0%)
$5.10 B(+26.0%)
Jun 2015
-
$2.04 B(+21.0%)
$4.05 B(+8.9%)
Mar 2015
-
$1.69 B(-339.1%)
$3.72 B(+3.7%)
Dec 2014
$3.58 B(-45.1%)
-$705.00 M(-168.6%)
$3.58 B(-40.3%)
Sep 2014
-
$1.03 B(-39.9%)
$6.00 B(-8.6%)
Jun 2014
-
$1.71 B(+9.8%)
$6.57 B(+0.4%)
Mar 2014
-
$1.55 B(-9.2%)
$6.55 B(+0.3%)
Dec 2013
$6.53 B(-6.5%)
$1.71 B(+7.4%)
$6.53 B(-5.8%)
Sep 2013
-
$1.59 B(-5.2%)
$6.93 B(-3.4%)
Jun 2013
-
$1.68 B(+9.4%)
$7.18 B(-0.2%)
Mar 2013
-
$1.54 B(-27.3%)
$7.19 B(+3.1%)
Dec 2012
$6.98 B(+41.3%)
$2.12 B(+14.9%)
$6.98 B(+10.1%)
Sep 2012
-
$1.84 B(+8.5%)
$6.34 B(+30.2%)
Jun 2012
-
$1.70 B(+28.1%)
$4.87 B(-3.1%)
Mar 2012
-
$1.32 B(-10.4%)
$5.03 B(+1.7%)
Dec 2011
$4.94 B(-17.9%)
$1.48 B(+300.8%)
$4.94 B(+42.7%)
Sep 2011
-
$368.85 M(-80.1%)
$3.46 B(+11.9%)
Jun 2011
-
$1.85 B(+49.6%)
$3.09 B(+149.6%)
Mar 2011
-
$1.24 B
$1.24 B
Dec 2010
$6.02 B(+3.8%)
-
-
Dec 2009
$5.80 B
-
-

FAQ

  • What is AbbVie annual EBITDA?
  • What is the all time high annual EBITDA for AbbVie?
  • What is AbbVie annual EBITDA year-on-year change?
  • What is AbbVie quarterly EBITDA?
  • What is the all time high quarterly EBITDA for AbbVie?
  • What is AbbVie quarterly EBITDA year-on-year change?
  • What is AbbVie TTM EBITDA?
  • What is the all time high TTM EBITDA for AbbVie?
  • What is AbbVie TTM EBITDA year-on-year change?

What is AbbVie annual EBITDA?

The current annual EBITDA of ABBV is $9.14 B

What is the all time high annual EBITDA for AbbVie?

AbbVie all-time high annual EBITDA is $24.17 B

What is AbbVie annual EBITDA year-on-year change?

Over the past year, ABBV annual EBITDA has changed by -$8.04 B (-46.79%)

What is AbbVie quarterly EBITDA?

The current quarterly EBITDA of ABBV is -$1.49 B

What is the all time high quarterly EBITDA for AbbVie?

AbbVie all-time high quarterly EBITDA is $7.53 B

What is AbbVie quarterly EBITDA year-on-year change?

Over the past year, ABBV quarterly EBITDA has changed by -$6.37 B (-130.51%)

What is AbbVie TTM EBITDA?

The current TTM EBITDA of ABBV is $12.88 B

What is the all time high TTM EBITDA for AbbVie?

AbbVie all-time high TTM EBITDA is $25.32 B

What is AbbVie TTM EBITDA year-on-year change?

Over the past year, ABBV TTM EBITDA has changed by -$5.34 B (-29.31%)